Table 3 Impact on gross and net cost-effectiveness ratios of changing the formulation from custom granule to the less expensive water dispersible formulation
From: Cost-effectiveness of larviciding for urban malaria control in Tanzania
Scenarios | Gross CER* | CER* Provider’s perspective | CER* Societal perspective |
|---|---|---|---|
Scenario #1 - Incidence rate of 902 per 1,000 | |||
 Infection averted | $3.5 | $2.7 | $1.5 |
 Death prevented | $3,222 | $2,528 | $1,395 |
 DALY averted | $62.6 | $49.1 | $27.1 |
Scenario #2 - Incidence rate of 227 per 1,000 | |||
 Infection averted | $13.8 | $13.0 | $11.8 |
 Death prevented | $12,824 | $12,130 | $10,997 |
 DALY averted | $249.2 | $235.7 | $213.7 |
Scenario #3 - Incidence rate of 122 per 1,000 | |||
 Infection averted | $25.6 | $24.9 | $23.6 |
 Death prevented | $23,850 | $23,155 | $22,023 |
 DALY averted | $463.4 | $449.9 | $427.9 |